542
Participants
Start Date
August 31, 2024
Primary Completion Date
January 31, 2027
Study Completion Date
December 31, 2028
TQB2102 for Injection
TQB2102 is a next-generation HER2 Antibody-Drug Conjugate (ADC) drug proposed for patients with HER2 low-expressing breast cancer.
Chemotherapy drug (Capecitabine/Paclitaxel/Albumin Paclitaxel)
"Based on each patient's condition and previous treatment history, the investigator will select one of the chemotherapy drugs for treatment.~* Capecitabine: 1000-1250 mg/m2 twice daily, administered consecutively on day 1-14, 21 days as a treatment cycle.~* Paclitaxel: 175 mg/m2, IV infusion, administered Day1 per cycle, 21 days as a treatment cycle. OR 80 mg/m2 by IV infusion administered weekly.~* Albumin Paclitaxel: 260 mg/m2, IV infusion, administered every cycle of Day1 for 21 days as a treatment cycle. 100 mg/m2 or 125 mg/m2, IV infusion, administered every cycle of Day 1 and Day 8 for 21 days as a treatment cycle; or Day 1, Day 8, and Day 15 administered every cycle for 28 days as a treatment cycle."
Chifeng Municipal Hospital, Chifeng
Beijing Cancer Hospital, Beijing
The Second Hospital of DALIAN Medical University, Dalian
Affiliated Cancer Hospital of Harbin Medical University, Harbin
Obstetrics & Gynecology Hospital of Fudan University, Shanghai
AnHui Province Hospital West District, Hefei
The first Affiliated hospital of anhui medical university, Hefei
The First Affiliated Hospital of Bengbu Medical University, Bengbu
Binzhou Medical College Affiliated Hospital, Binzhou
Affiliated Hangzhou First People's Hospital, Hangzhou
Binzhou People's Hospital, Binzhou
Fujian Medical University 2nd Affiliated Hospital, Quanzhou
Zhangzhou Hospital in Fujian Province, Zhangzhou
Tongji Hospital Tongji Medical College of HUST, Wuhan
Hubei Cancer Hospital, Wuhan
Henan Cancar Hospital, Zhengzhou
AnYang Tumor Hospital, Anyang
The First Affiliated Hospital of Henan University of Science & Technology, Luoyang
Sun Yet-Sen University Cancer Certer, Guangzhou
Affiliated Hospital of Guangdong Medical University, Zhanjiang
Cancer Hospital Affiliated to Guangxi Medical University, Nanning
The First affiliated hospital of GuangXi medical university, Nanning
Guigang City People'S Hospital, Guigang
The Affiliated Cancer Hospital of Guizhou Medical University Co., LTD, Guiyang
Guizhou Provincial People's Hospital, Guiyang
The First Affiliated Hospital of Hainan Medical College, Haikou
Hainan General Hospital, Haikou
Affiliated Hospital of North Scichuan Medical College, Nanchong
Baoji Central Hospital, Baoji
Gansu Provincial Hospital, Lanzhou
Gansu Wuwei Tumour Hospital, Wuwei
Gansu Provincial Cancer Hospital, Lanzhou
Affiliated Hospital of Hebei University, Baoding
Chengde Central Hospital, Chengde
Lead Sponsor
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
INDUSTRY